Search results
Antidepressants Differ by Long-Term Response in Major Depression
Psychiatric Times· 3 days agoAntidepressants differ in improving symptoms and preventing relapse of major depressive disorder...
First patient treated in Actinogen's XanaMIA phase 2b Alzheimer's disease trial
WDTN-TV 2 Dayton· 1 week agoActinogen Medical Limited (ASX: ACW) announces that the first patient has been randomized and treated in the XanaMIA phase 2b clinical trial< ...
Revolutionary Relief: Esketamine Reduces Postpartum Depression by 75%
SciTechDaily· 1 week agoA clinical trial recently published in The BMJ reports that administering a single low dose of...
Brain Stimulation Shows Promise for Alleviating Depression and Anxiety
SciTechDaily· 6 days agoA University of Florida study indicates that transcranial direct current stimulation (tDCS) effectively alleviates depression and anxiety in older adults ...
Severity of TRD Predicts Ketamine vs ECT Response
Medscape· 1 day agoThe severity of TRD appeared to predict response to IV ketamine vs ECT. However, experts said more research is needed before drawing any definitive conclusions.
Many mental-health conditions have bodily triggers
The Economist· 16 hours agoTHE TICS started when Jessica Huitson was only 12 years old. In fact, Jessica had an autoimmune condition brought on by a bacterial infection with Streptococcus. Ms Huitson is not alone in having ...
Enrolment completed in Actinogen's XanaCIDD phase 2a cognition & depression trial
WPRI Providence· 3 days agoThe XanaCIDD trial is a proof-of-concept, placebo-controlled, parallel group trial with a six-week treatment period and four weeks of ...
Neurocrine reports promising phase 2 depression drug data By Investing.com
Investing.com· 2 days agoThe study, termed the SAVITRIā¢ study, is a randomized, double-blind, placebo-controlled dose-finding...
Ketamine Reduces Depression After Childbirth, Study Finds
Technology Networks· 2 weeks agoThe research, published in The British Medical Journal, suggests esketamine treatment could be...
Postpartum low-dose esketamine aids moms with prenatal depression
Medical Xpress· 5 days agoA single low dose of esketamine after childbirth reduces depressive episodes at 42 days postpartum...